Using this structure, our protein structural modeling predicted that the schizophrenia-related missense mutations identified in SAP97’s PDZ2 domain will inhibit SAP97’s ability to associate with GluA1’s PDZ-binding domain (Fig. 5b and Supplementary Fig. 5). This evidence concerns the gene DLG1 and schizophrenia.